ANI Pharmaceuticals | ANIP - Loan Capital


ANI Pharmaceuticals reported $297.68M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
AbbVie USD 62.97B 12M Sep/2025
ANI Pharmaceuticals USD 297.68M 310.67M Sep/2025
Assertio Holdings USD 39.17M 120K Sep/2025
Aurora Cannabis CAD 34.99M 1.31M Sep/2025
Canopy Growth CAD 226.33M 62.67M Sep/2025
Eli Lilly USD 40.87B 5.6M Dec/2025
Emergent BioSolutions USD 446.5M 1.7M Dec/2023
Heron Therapeutics USD 149.65M 157K Sep/2024
Hikma Pharmaceutical USD 798M 191M Jun/2025
Knight Therapeutics CAD 36.51M 2.04M Sep/2024
Nektar Therapeutics USD 107.51M 10.35M Jun/2024
Novartis USD 24.24B 174M Sep/2025
Omeros USD 403.72M 27.2M Jun/2024
Perrigo USD 3.61B 7.4M Sep/2025
Sun Pharmaceuticals INR 3.62B 36.4M Sep/2025
Teva Pharmaceutical Industries USD 14.99B 1.78B Dec/2025